Naples Global Advisors, Llc reports 1.44% increase in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,43 € ↓ -0,01 (-0,01%)

2026-06-04
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Naples Global Advisors, Llc
Latest Disclosed Ownership	86,761 shares
Latest Disclosed Value	$ 5,262,038

On April 20, 2026 - Naples Global Advisors, Llc filed a 13F-HR form disclosing ownership of 86,761 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $4,548,012 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 85,530 shares of Bristol-Myers Squibb Company. This represents a change in shares of 1.44% during the quarter. The current value of the position is $4,115,074 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-04-20	2026-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	86,761	1,231	1.44	5,262	14.07	0.3839
2026-02-04	2025-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	85,530	3,887	4.76	4,614	25.29	0.3447
2025-10-30	2025-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	81,643	2,130	2.68	3,682	0.05	0.2867
2025-07-18	2025-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	79,513	-1,330	-1.65	3,681	-25.35	0.3167
2025-04-10	2025-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	80,843	334	0.41	4,931	8.28	0.4685
2025-01-29	2024-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	80,509	35	0.04	4,554	9.37	0.4259
2024-10-24	2024-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	80,474	-2,112	-2.56	4,164	21.41	0.3871
2024-07-18	2024-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	82,586	-217	-0.26	3,430	-23.63	0.3442
2024-04-29	2024-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	82,803	7,365	9.76	4,490	16.02	0.4597
2024-01-11	2023-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	75,438	9,489	14.39	3,871	1.12	0.4257
2023-10-16	2023-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	65,949	6,836	11.56	3,828	1.24	0.4639
2023-07-17	2023-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	59,113	3,188	5.70	3,780	-2.48	0.4435
2023-04-17	2023-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	55,925	2,193	4.08	3,876	0.28	0.4832
2023-04-17	2022-12-31	13F/A-1	BRISTOL-MYERS SQUIBB	COM	110122108	53,732	253	0.47	3,866	1.66	0.4913
2023-01-20	2022-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	53,732	253		3,866		0.0005
2022-10-20	2022-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	53,479	3,130	6.22	3,802	-2.56	0.5233
2022-08-11	2022-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	50,349	679	1.37	3,902	7.58	0.5064
2022-04-28	2022-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	49,670	2,283	4.82	3,627	22.74	0.4188
2022-02-04	2021-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	47,387	2,687	6.01	2,955	11.72	0.3424
2021-10-29	2021-09-30	13F/A-1	BRISTOL-MYERS SQUIBB	COM	110122108	44,700	7,177	19.13	2,645	5.50	0.3474
2021-10-25	2021-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	44,700	7,177		2,645		0.3457
2021-08-06	2021-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	37,523	3,532	10.39	2,507	16.82	0.3486
2021-05-10	2021-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	33,991	2,037	6.37	2,146	8.27	0.3261
2021-02-08	2020-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	31,954	356	1.13	1,982	4.04	0.3351
2020-10-26	2020-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	31,598	1,647	5.50	1,905	8.18	0.3713
2020-08-04	2020-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	29,951	3,612	13.71	1,761	19.96	0.3794
2020-04-27	2020-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	26,339	224	0.86	1,468	-12.41	0.3847
2020-02-05	2019-12-31	13F	Bristol-Myers Squibb	COM	110122108	26,115	670	2.63	1,676	29.92	0.3519
2019-10-28	2019-09-30	13F	Bristol-Myers Squibb	COM	110122108	25,445	1,201	4.95	1,290	17.38	0.3013
2019-07-10	2019-06-30	13F	Bristol-Myers Squibb	COM	110122108	24,244	2,112	9.54	1,099	4.07	0.2674
2019-04-29	2019-03-31	13F	Bristol-Myers Squibb	COM	110122108	22,132	1,035	4.91	1,056	4.87	0.2700
2019-02-01	2018-12-31	13F	Bristol-Myers Squibb	COM	110122108	21,097	283	1.36	1,007	-22.06	0.2866
2018-11-13	2018-09-30	13F/A-1	Bristol-Myers Squibb	COM	110122108	20,814	643	3.19	1,292	15.77	0.3428
2018-11-13	2018-09-30	13F	Bristol-Myers Squibb	COM	110122108	20,171	0		1,116
2018-07-23	2018-06-30	13F	Bristol-Myers Squibb	COM	110122108	20,171	2,404	13.53	1,116	-0.71	0.3144
2018-04-17	2018-03-31	13F	Bristol-Myers Squibb	COM	110122108	17,767	99	0.56	1,124	3.79	0.3335
2018-01-19	2017-12-31	13F	Bristol-Myers Squibb	COM	110122108	17,668	1,049	6.31	1,083	2.27	0.3198
2017-10-16	2017-09-30	13F	Bristol-Myers Squibb	COM	110122108	16,619	248	1.51	1,059	16.12	0.3535
2017-07-25	2017-06-30	13F	Bristol-Myers Squibb	COM	110122108	16,371	0	0.00	912	2.47	0.3235
2017-04-21	2017-03-31	13F	Bristol-Myers Squibb	COM	110122108	16,371	95	0.58	890	-6.41	0.3194
2017-01-30	2016-12-31	13F	Bristol-Myers Squibb	COM	110122108	16,276	-2,810	-14.72	951	-7.58	0.3703
2016-10-11	2016-09-30	13F	Bristol-Myers Squibb	COM	110122108	19,086	4,000	26.51	1,029	-7.30	0.4024
2016-07-13	2016-06-30	13F	Bristol-Myers Squibb	COM	110122108	15,086	500	3.43	1,110	19.10	0.4543
2016-04-13	2016-03-31	13F	Bristol-Myers Squibb	COM	110122108	14,586	10,510	257.85	932	232.86	0.3906
2016-01-25	2015-12-31	13F	Bristol-Myers Squibb	COM	110122108	4,076	0	0.00	280	16.18	0.1357
2015-10-14	2015-09-30	13F	Bristol-Myers Squibb	COM	110122108	4,076	0	0.00	241	-11.07	0.1238
2015-07-27	2015-06-30	13F	Bristol-Myers Squibb	COM	110122108	4,076	0	0.00	271	3.04	0.1301
2015-04-15	2015-03-31	13F	Bristol-Myers Squibb	COM	110122108	4,076	338	9.04	263	19.00	0.1250
2015-01-22	2014-12-31	13F	Bristol-Myers Squibb	COM	110122108	3,738	3,738		221		0.1169

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.